Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls

David G. Standaert(University of Alabama at Birmingham), Katherine B. Gloer, Vanessa Arnedo, Eric D. Foster, Catherine Kopil, John Q. Trojanowski(University of Pennsylvania), Chelsea Caspell, Karen Crawford(University of Southern California), Paola Casalin(University of Iowa), Jon Yankey(University of Iowa), Karl Kieburtz(Beth Israel Deaconess Medical Center), John Seibyl(Elucid Bioimaging), Andy Singleton(University of Iowa), Norbert Schuff(University of California, Davis), Danna Jennings, Tatiana Foroud(University of Southern California), Penelope Hogarth, Shirley Lasch(Institute for Neurodegenerative Disorders), Werner Poewe(Innsbruck Medical University), Stewart A. Factor(Parkinson's and Movement Disorder Institute), Peggy Taylor(University of Iowa), Giulia Malferrari(University of Iowa), Chelsea Caspell‐Garcia(University of Iowa), Douglas Galasko(University of Minnesota), Keith A. Hawkins, Caroline M. Tanner(University of California, San Francisco), Sohini Chowdhury, Brit Mollenhauer(Paracelsus Elena Klinik Kassel), Liz Uribe(AbbVie (United States)), Mark Frasier(Michael J. Fox Foundation), Leslie M. Shaw(California University of Pennsylvania), Arthur W. Toga(University of Southern California), Christopher S. Coffey(University of Iowa), Renée Wilson(University of Iowa), Cynthia Casaceli, Tanya Simuni
Neurology
October 14, 2017
Cited by 152


Related Papers